We showed that the serum levels of CXCL9, CXCL10, and CXCL11 and the BALF levels of CXCL9 and CXCL10 were higher in patients with CVD–ILD and IPAF than in those with IPF. This evidence concerns the gene CXCL9 and idiopathic pulmonary fibrosis.